Ana Montes

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz et al. · The Lancet Oncology · 2021 · 612 citations · Full text

Veterinary Medicine, Immunology, Oncology +14

An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor

Martin Gore, Allan Hackshaw, William E. Brady et al. · Gynecologic Oncology · 2019 · 104 citations · Full text

Medicine, Gynecology, Oncology +11

Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes

Heather J. Bax, Jitesh Chauhan, Chara Stavraka et al. · British Journal of Cancer · 2022 · 85 citations · Full text

Medicine, Cancer Biology, Oncology +17

Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 Signaling

Debra H. Josephs, Heather J. Bax, Tihomir Dodev et al. · Cancer Research · 2017 · 79 citations · Full text

Life Sciences, Immunology, Oncology +17

Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines

Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz et al. · medRxiv · 2021 · 61 citations · Full text

Veterinary Medicine, Immunology, Oncology +17